23 min
Special episode featuring James Mackay - November 2021 P4A Let's Talk Rare
-
- Science
This episode featuring James Mackay, President & CEO of Aristea Therapeutics. James provides insights on his experience with setting up a biotech and challenges associated, industry climate on spin off opportunities, Aristea’s pipeline, collaborations and US PRMA reforms.
Presenter: Aparna Krishnan
Contributors: James Mackay, President & CEO of Aristea Therapeutics
Producer: Operations team
About Aristea Therapeutics, a San Diego-based clinical-stage immunology-focused drug development company developing novel therapies for serious, rare inflammatory diseases.
This episode featuring James Mackay, President & CEO of Aristea Therapeutics. James provides insights on his experience with setting up a biotech and challenges associated, industry climate on spin off opportunities, Aristea’s pipeline, collaborations and US PRMA reforms.
Presenter: Aparna Krishnan
Contributors: James Mackay, President & CEO of Aristea Therapeutics
Producer: Operations team
About Aristea Therapeutics, a San Diego-based clinical-stage immunology-focused drug development company developing novel therapies for serious, rare inflammatory diseases.
23 min